WallStreetZenWallStreetZen

NYSE: HAE
Haemonetics Corp Stock Forecast, Predictions & Price Target

Analyst price target for HAE

Based on 5 analysts offering 12 month price targets for Haemonetics Corp.
Min Forecast
$95.00+7.8%
Avg Forecast
$106.40+20.73%
Max Forecast
$115.00+30.49%

Should I buy or sell HAE stock?

Based on 5 analysts offering ratings for Haemonetics Corp.
Buy
Strong Buy
1 analysts 20%
Buy
2 analysts 40%
Hold
2 analysts 40%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HAE stock forecasts and price targets.

HAE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Barrington Research
Bottom 18%
18
BuyMaintains$111.00+25.95%2023-05-12
Morgan Stanley
Top 19%
82
HoldMaintains$96.00+8.93%2023-05-12
JMP Securities
Bottom 8%
8
BuyMaintains$115.00+30.49%2023-05-12
Citigroup
Top 3%
98
HoldMaintains$95.00+7.80%2023-02-08
Mizuho
Top 9%
92
Strong BuyMaintains$115.00+30.49%2023-02-08

1 of 1

Forecast return on equity

Is HAE forecast to generate an efficient return?
Company
26.57%
Industry
0.51%
Market
71.95%
HAE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HAE forecast to generate an efficient return on assets?
Company
11.23%
Industry
0.22%
HAE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HAE earnings growth forecast

How is HAE forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
23.43%
Industry
32.25%
Market
25.59%
HAE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
HAE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
HAE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

HAE revenue growth forecast

How is HAE forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
4.08%
Industry
6.62%
Market
8.44%
HAE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HAE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HAE vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
HAE$88.13$106.40+20.73%Buy
ICUI$184.46N/AN/A
MMSI$84.35$85.17+0.97%Buy
NVST$32.96$45.00+36.53%Strong Buy
IRTC$105.66$150.88+42.79%Strong Buy

Haemonetics Stock Forecast FAQ

Is Haemonetics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NYSE: HAE) stock is to Buy HAE stock.

Out of 5 analysts, 1 (20%) are recommending HAE as a Strong Buy, 2 (40%) are recommending HAE as a Buy, 2 (40%) are recommending HAE as a Hold, 0 (0%) are recommending HAE as a Sell, and 0 (0%) are recommending HAE as a Strong Sell.

If you're new to stock investing, here's how to buy Haemonetics stock.

What is HAE's forecast return on equity (ROE) for 2024-2026?

(NYSE: HAE) forecast ROE is 26.57%, which is considered strong.

What is HAE's Price Target?

According to 5 Wall Street analysts that have issued a 1 year HAE price target, the average HAE price target is $106.40, with the highest HAE stock price forecast at $115.00 and the lowest HAE stock price forecast at $95.00.

On average, Wall Street analysts predict that Haemonetics's share price could reach $106.40 by May 12, 2024. The average Haemonetics stock price prediction forecasts a potential upside of 20.73% from the current HAE share price of $88.13.

What is HAE's forecast return on assets (ROA) for 2024-2026?

(NYSE: HAE) forecast ROA is 11.23%, which is higher than the forecast US Medical Instruments & Supplies industry average of 0.22%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.